Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Plérixafor")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 69

  • Page / 3
Export

Selection :

  • and

The evolving role of plerixafor in hematopoietic progenitor cell mobilizationTANHEHCO, Yvette C; VOGL, Dan T; STADTMAUER, Edward A et al.Transfusion (Philadelphia, PA). 2013, Vol 53, Num 10, pp 2314-2326, issn 0041-1132, 13 p., 1Article

Prospective study of mobilization kinetics up to 18 hours after late-afternoon dosing of plerixaforSHI, Patricia A; MILLER, Lorraine K; ISOLA, Luis M et al.Transfusion (Philadelphia, PA). 2014, Vol 54, Num 5, pp 1263-1268, issn 0041-1132, 6 p.Article

Plerixafor 'just in time' for stem cell mobilization in a normal donorSCHRIBER, J; FAUBLE, V; SPROAT, L. O et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 7, pp 1026-1027, issn 0268-3369, 2 p.Article

Experience with Plerixafor for Hematopoietic Cell Mobilization in Nine Patients with Germ Cell TumorsO'HARA, V. J. Daphne; KARR, Alissa H; SRIVASTAVA, Shivani et al.Pharmacotherapy. 2014, Vol 34, Num 1, pp 85-88, issn 0277-0008, 4 p.Article

Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administrationHORWITZ, M. E; CHUTE, J. P; GASPARETTO, C et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 8, pp 1051-1055, issn 0268-3369, 5 p.Article

Genetics on a WHIMOMAR AL USTWANI, Omar; KURZROCK, Razelle; WETZLER, Meir et al.British journal of haematology. 2014, Vol 164, Num 1, pp 15-23, issn 0007-1048, 9 p.Article

Clinical experience with a simple algorithm for plerixafor utilization in autologous stem cell mobilizationCHEN, Al; BAINS, T; MURRAY, S et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 12, pp 1526-1529, issn 0268-3369, 4 p.Article

Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use programHÜBEL, K; FRESEN, M. M; HEITS, F et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 8, pp 1045-1052, issn 0268-3369, 8 p.Article

Rescue from failed growth factor and/or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experienceFOWLER, C. J; DUNN, A; MAZIARZ, R. T et al.Bone marrow transplantation (Basingstoke). 2009, Vol 43, Num 12, pp 909-917, issn 0268-3369, 9 p.Article

A specific time course for mobilization of peripheral blood CD34+ cells after plerixafor injection in very poor mobilizer patients: impact on the timing of the apheresis procedureLEFRERE, François; MAUGE, Laeticia; REA, Delphine et al.Transfusion (Philadelphia, PA). 2013, Vol 53, Num 3, pp 564-569, issn 0041-1132, 6 p.Article

Effectiveness and cost analysis of just-in-time salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kineticsJIE LI; HAMILTON, Ellie; LONIAL, Sagar et al.Transfusion (Philadelphia, PA). 2011, Vol 51, Num 10, pp 2175-2182, issn 0041-1132, 8 p.Article

Plérixafor (Mozobil) Juste pour rattraper chez quelques malades des échecs de mobilisation de cellules souches = Plerixafor (Mozobil)for stem cell mobilizationLa Revue Prescrire. 2010, Vol 30, Num 318, pp 247-250, issn 0247-7750, 4 p.Article

Plerixafor on-demand combined with chemotherapy and granulocyte colony-stimulating factor: significant improvement in peripheral blood stem cells mobilization and harvest with no increase in costsMILONE, Giuseppe; MARTINO, Massimo; TRIPEPI, Giovanni et al.British journal of haematology. 2014, Vol 164, Num 1, pp 113-123, issn 0007-1048, 11 p.Article

Similar dynamics of intraapheresis autologous CD34+ recruitment and collection efficiency in patients undergoing mobilization with or without plerixaforSCHADE, Henning; CHHABRA, Saurabh; COSTA, Luciano J et al.Transfusion (Philadelphia, PA). 2014, Vol 54, Num 12, pp 3131-3137, issn 0041-1132, 7 p.Article

Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSFBASAK, G. W; WIKTOR-JEDRZEJCZAK, W; LEMOLI, R et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 7, pp 1003-1005, issn 0268-3369, 3 p.Article

Successful mobilization of PBSCs in a healthy volunteer donor by addition of plerixafor after failure of mobilization with G-CSF aloneNEUMANN, T; KRÜGER, W. H; BUSEMANN, C et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 5, pp 762-763, issn 0268-3369, 2 p.Article

La mobilisation des progéniteurs hématopoïétiques: nouvelles cibles et nouvelles modalités thérapeutiques = New molecular targets and new clinical practices for hematopoietic stem cell mobilisationCHABANNON, Christian; CALMELS, Boris; HABIBI, Sarah et al.Bulletin du cancer. 2011, Vol 98, Num 8, pp 951-961, issn 0007-4551, 11 p.Article

Addition of plerixafor for CD34+ cell mobilization in six healthy stem cell donors ensured satisfactory grafts for transplantationHAUGE, Anne Werner; HAASTRUP, Eva Kannik; SENGELØV, Henrik et al.Transfusion (Philadelphia, PA). 2014, Vol 54, Num 4, pp 1055-1058, issn 0041-1132, 4 p.Article

Second time a charm? Remobilization of peripheral blood stem cells with plerixafor in patients who previously mobilized poorly despite using plerixafor as a salvage agentSHAN YUAN; NADEMANEE, Auayporn; KRISHNAN, Amrita et al.Transfusion (Philadelphia, PA). 2013, Vol 53, Num 12, pp 3244-3250, issn 0041-1132, 7 p.Article

Safe and effective use of plerixafor plus G-CSF in dialysis-dependent renal failurePINTO, Valeria; CASTELLI, Andrea; GAIDANO, Gianluca et al.American journal of hematology. 2010, Vol 85, Num 6, pp 461-462, issn 0361-8609, 2 p.Article

AMD3100 for urgent PBSC mobilization and allogeneic transplantation from a normal donor after failed marrow harvestLEOTTA, S; POIDOMANI, M; MAURO, E et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 2, pp 314-316, issn 0268-3369, 3 p.Article

Plerixafor given before the third leukapheresis to rescue an unsuccessful stem cell mobilization with CY and G-CSFNIMMAGADDA, S; SWEISS, K; MAHMUD, N et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 6, pp 1121-1122, issn 0268-3369, 2 p.Article

Long-term follow up of patients proceeding to transplant using plerixafor mobilized stem cells and incidence of secondary myelodysplastic syndrome/AMLDEOL, A; ABRAMS, J; MASOOD, A et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 8, pp 1112-1116, issn 0268-3369, 5 p.Article

European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilizationHÜBEL, K; FRESEN, M. M; LANZA, F et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 8, pp 1046-1050, issn 0268-3369, 5 p.Article

Growth factor plus preemptive ('just-in-time') plerixafor successfully mobilizes hematopoietic stem cells in multiple myeloma patients despite prior lenalidomide exposureCOSTA, L. J; ABBAS, J; HOGAN, K. R et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 11, pp 1403-1408, issn 0268-3369, 6 p.Article

  • Page / 3